ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Repeat Aortic Valve Surgery or Transcatheter Valve-in-Valve Therapy: We Need a Randomized Trial
Saturday, August 1, 2020
Submitted by
Source
Source Name: Journal American College of Cardiology
Source URL: https://pubmed.ncbi.nlm.nih.gov/32731927/
This JANS Note is an editorial in response to a recent publication by Deharo et al comparing TAVR valve-in-valve versus redo-SAVR demonstrating improved short-term outcomes with TAVR ViV. The detail limitations of this study and provide a persuasive argument for the need of a randomized trial comparing both modalities.
Printer-friendly
